Voce et al. [130] showed temozolomide treatment-induced lncRNA MALAT1 in an NF-κB and p53 co-dependent manner in glioblastoma cells, which supported MALAT1 as a target for chemosensitization of glioblastoma [130]. Here, MALAT1 is linked to glioblastoma.